Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, et al. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. Leukemia 2022 May 13. pii: 10.1038/s41375-022-01582.
PMID: 35562406